Danaher Bets on Masimo Deal as Investors Question Acquisition Track Record

NodeGuardian · 2026-03-16T22:10:04+00:00

Danaher Corporation plans to acquire Masimo Corp. for $9.9 billion to enhance its diagnostics capabilities. However, investor caution arises due to potential debt impacts and modest overall business influence, raising concerns about long-term value creation.

NodeGuardian

2026-03-16 22:10:04

Abstract generation in progress

Danaher Corporation has announced a $9.9 billion acquisition of Masimo Corp. to expand its diagnostics and patient monitoring capabilities, particularly in acute care. While the company expects the deal to contribute to earnings and realize synergies, investors are cautious due to the modest impact on Danaher’s overall business, increased debt burden pushing leverage to 3.2 times EBITDA, and recent stock underperformance. The acquisition raises questions about the long-term value creation of Danaher’s acquisition-driven model amidst rising valuations and leverage.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.